ReviveHealth

ReviveHealth operates as an early-stage venture capital firm with a proprietary co-investment and sourcing model. The firm's Expert Network brings together over 100 senior health-system executives who generate deal flow, conduct operational due diligence, and often co-invest alongside the fund. This structure gives ReviveHealth visibility into the purchasing priorities of large provider organizations before those priorities become widely recognized by generalist VCs.

Network members, typically CIOs, CMOs, and innovation officers from large US health systems, evaluate potential portfolio companies against real-world clinical and operational requirements. They assess whether a startup's product can integrate into existing EHR workflows, clear procurement hurdles, and demonstrate measurable ROI — questions that are difficult for non-operator investors to diligence independently. The firm uses this feedback to inform investment committee decisions and to match portfolio companies with design partners.

Yes, the firm raises closed-end venture capital funds. The Expert Network members may participate as limited partners or as co-investors on a deal-by-deal basis through special purpose vehicles, depending on the fund's agreement structure. The firm leads and co-leads rounds, typically reserving capital for follow-on investments through subsequent fund vintages.

The firm focuses on early-stage digital health and healthcare enterprise software companies that sell into hospitals, health systems, and large physician groups. Areas of particular interest have included behavioral health platforms, care coordination and navigation tools, clinical workflow automation, and AI-driven operational efficiency applications. The common thread across investments is a direct enterprise sales motion into provider organizations.

ReviveHealth concentrates on Seed and Series A investments, where the combination of product risk and commercial risk is highest and where the Expert Network's ability to de-risk go-to-market strategy provides the greatest advantage. The firm looks for companies with at least an early version of a product and some pilot evidence, then helps accelerate enterprise adoption through its provider relationships.

While many digital health VC firms employ clinical advisors or maintain informal provider relationships, ReviveHealth structurally integrates its sourcing and diligence process into a standing community of hundred-plus health-system executives. These executives are not passive advisors — they are active referrers of deals, participants in diligence, and often the first commercial buyers of a portfolio company's product. This shifts the firm's information edge from financial analysis toward operational and procurement intelligence.

Nigel Waller spent over a decade in innovation and technology leadership roles within the UK's National Health Service before founding ReviveHealth in 2015. His experience inside a large single-payer system gave him direct exposure to the procurement cycles, regulatory constraints, and clinical workflow integration challenges that define enterprise healthtech sales — a perspective he built the firm's Expert Network model to replicate at scale across the US provider landscape.